Led by CEO Alexander Ballatori, StrokeDx specializes in developing advanced technologies and software to enable portable, non-invasive, non-radiating cerebrovascular monitoring. The company’s innovative approach offers a precise method to survey strokes using next-generation technology developed by Shane Shahrestani, MD, PhD, at the California Institute of Technology (Caltech).